Searchable abstracts of presentations at key conferences in endocrinology

ea0090p398 | Endocrine-related Cancer | ECE2023

Severe insulin secretion by an inoperable metastatic insulinoma can be controlled by 177-Lu-DOTA-TATE radionuclide therapy: a case report

Riley George , Creton Cecile , Demarquet Lea , Raymond Perrine , Chevalier Elodie , Lambert Aurelien , Guerci Bruno , Klein Marc , Scheyer Nicolas

Introduction: Metastatic insulinoma is an extremely rare form of malignant insulinoma involving metastatic growth where classical surgical treatment is often impossible. Medical therapies are widely considered and reserved for those especially with inoperable insulinoma with the goals of reducing tumor size, but also of reducing hypoglycemic events either by acting directly on the insulinoma cells (reducing excess insulin secretion from the insulinoma cells or reducing tumor v...